Something was needed.” That “something” was discovering magic mushrooms two years ago. The Hertfordshire couple are following a trend, it seems, for professional (and presumably often ...

Microdosing is gaining popularity with a new breed of health-seekers. These self-experimenters take a very small amount of ...

The Cleveland Clinic is part of a multisite trial studying psilocybin to help patients with treatment-resistant depression.

Such a dynamic was in evidence with U.K.-based Compass Pathways (NASDAQ: CMPS) this week. On news about a step completed in a ...

Some researchers believe it’s the main compound responsible for the psychedelic effects of magic mushrooms that may ... to cause common side effects after dosing day and ...

Mushroom Matchup is part of the Dose Denver campaign led by Plant Magic's private ministerial association, the Entheosacrament Association. The campaign includes several events themed around ...

Compass Pathways, which focuses on psilocybin -- the psychoactive compound found in "magic" mushrooms -- announced Tuesday that it had completed dosing in a late-stage clinical trial. The biotech ...